The common practice of administering heparin soon after cardioembolic stroke is associated with an increased risk for serious bleeding, according to an article in the Archives of Neurology. However, ...

Many patients requiring pacemaker or implantable cardioverter–defibrillator (ICD) surgery are taking warfarin. For patients at high risk for thromboembolic events, guidelines recommend bridging ...

January 19, 2011 (San Diego, California) — Subcutaneously administered heparin might not provide optimal protection against venous thromboembolism (VTE) for patients who have undergone major abdominal ...

Please provide your email address to receive an email when new articles are posted on . Patients with an allergic inflammatory skin reaction to subcutaneous heparin generally tolerated IV ...

Ischemic stroke is a leading cause of death and disability in the Western world. At present, intravenous administration of tissue plasminogen activator within 3 h of symptom onset is the only proven ...

The U.S. Food and Drug Administration today alerted health care professionals to a change in heparin manufacturing that is expected to decrease the potency of the common anti-clotting drug. To ensure ...

The IV heparin recommended by Peter F. Cohn, MD, as bridging therapy when warfarin has to be stopped in a pa-tient with an artificial heart valve (Item 99-12) requires a long hospital stay. Why not ...

Baxter has announced that providers at a hospital in Delaware, along with U.S. health officials, are looking into whether the deaths of two patients there were linked to a brand of Baxter's ...